{"prompt": "['Alliance A171601', 'Patient-completed questionnaire booklets for this study are to be ordered prior to the', 'registration of any patients (see Section 4.3). Samples of the booklets in English are', 'found in Appendices II-VII and electronic versions of the booklets in Spanish are', 'available on the Alliance and CTSU web sites, for reference and IRB submission only.', 'They are not to be used for patient completion. Booklets must be given to patients to', 'complete and patients should be instructed to return the booklets to site staff either in', 'person or by mail and site staff will enter patient and caregiver responses into Rave.', '6.1.3 Data Quality Portal:', 'The Data Quality Portal (DQP) provides a central location for site staff to manage', 'unanswered queries and form delinquencies, monitor data quality and timeliness, generate', 'reports, and review metrics.', \"The DQP is located on the CTSU members' website under Data Management. The Rave\", 'Home section displays a table providing summary counts of Total Delinquencies and Total', 'Queries. DQP Queries, DQP Delinquent Forms and the DQP Reports modules are available', 'to access details and reports of unanswered queries, delinquent forms, and timeliness', 'reports. Review the DQP modules on a regular basis to manage specified queries and', 'delinquent forms.', 'The DQP is accessible by site staff that are rostered to a site and have access to the CTSU', 'website. Staff that have Rave study access can access the Rave study data using a direct', 'link on the DQP.', 'To learn more about DQP use and access, click on the Help icon displayed on the Rave', 'Home, DQP Queries, and DQP Delinquent Forms modules.', 'Note: Some Rave protocols may not have delinquent form details or reports specified on', 'the DQP. A protocolmust have the Calendar functionality implemented in Rave by the', 'Lead Protocol Organization for delinquent form details and reports to be available on the', 'DQP. Site staff should contact the LPO Data Manager for their protocol regarding', 'questions about Rave Calendaring functionality.', '6.1.4 Supporting documentation', 'This study requires supporting documentation for diagnosis, response, progression and', 'survival. Supporting documentation will include pathology and imaging reports and must', 'be submitted at the following time points:', 'Baseline: For patients with measurable disease only, pathology and imaging reports.', 'At Progression and response: Imaging reports and/or clinic notes, based on standard', 'RECIST criteria.', 'All supporting documentation should be de-identified according to institutional standards', 'prior to upload into RAVE.', '25', 'NCIVersion Date: 5/29/2020', 'Update 5']['Alliance A171601', '6.2', 'Specimen collection and submission', 'For patients registered to substudy A171601-ST1, A171601-ST2 and A171601-PP1: All', 'participating institutions must ask patients for their consent to participate in the correlative', 'substudies planned for Alliance A171601-ST1, A171601-ST2 and A171601-PP1, although', 'patient participation is optional. Biomarker, pharmacogenetic studies and pharmac okinetic', 'studies will be performed. Rationale and methods for the scientific components of these studies', 'are described in Section 14.0. For patients who consent to participate, plasma and whole blood', 'will be collected at the following time points for these studies: Collection of plasma for toxicity', 'biomarker correlative studies will coincide with the Geriatric assessment on cycle 1 day 1, and', 'prior to cycle 4.', 'For all patients registered to A171601 ST1, A171601- - ST2 and A171601-PP1, submit the following:', 'Prior to', 'Cycles 1 & 2', 'Day 15 (Prior to', 'Storage/Shipping', 'Treatment', 'Prior to Cycle 4', 'Submit to:', 'conditions', 'treatment)', 'Whole Blood', '(EDTA/lavender', '10 mL', '10 mL', 'Cool pack/ship over', 'Mayo BAP', 'night', 'Freezer', 'top)', 'Whole Blood2', 'Cool pack/ship over', 'Mayo BAP', '(EDTA/lavender', '10 mL', 'night', 'Freezer', 'top)', 'Plasma from', 'Whole Blood\u00b3', 'University', '5 mL', '5 mL', 'Dry ice/ ship over', 'of', '(EDTA/lavender', 'night', 'Pittsburgh', 'top)', '1', 'Whole blood for Plasma to be used for biomarker analyses described in Section 14.1.', '2', 'Whole blood to be used for pharmacogenomic analyses described in Section 14.2.', '3', 'Pharmacokinetic analyses described in Section 14.3. Patients will be asked to complete a', 'pharmacokinetics questionnaire (Appendix ] IX) these visits (Baseline, Cycles 1 &2 Day', '15, prior to treatment). The questionnaire can be completed before or after the blood', 'draw. A copy of the questionnaire will be sent by site staff along with the samples to the', 'University of Pittsburgh. Questionnaire responses are to be entered into Rave by site', 'staff.', 'Note: Samples for A171601- PP1 substudy are only required for patients who are', 'registered (and consent to participate in the substudies) after Update 1. Patients enrolled', 'prior to the release of Update 1 will not be asked to provide additional samples.', '6.2.1 Specimen Submission Using the Alliance Biospecimen Management System', 'USE OF THE ALLIANCE BIOSPECIMEN MANAGEMENT SYSTEM (BioMS) IS', 'MANDATORY AND ALL SPECIMENS MUST BE LOGGED AND SHIPPED VIA THIS', 'SYSTEM.', 'BioMS is a web-based system for logging and tracking all biospecimens collected on', 'Alliance trials. Authorized individuals may access BioMS at the following URL:', 'using most standard web browsers', '(Safari, Firefox, Internet Explorer). For information on using the BioMS system, pleaserefer', 'to the \"Help\\' links on the BioMS webpage to access the on-line user manual, FAQs, and', '26', 'NCI Version Date: 5/29/2020', 'Update 5']\n\n###\n\n", "completion": "END"}